Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
149.22
+1.18 (0.80%)
At close: Dec 5, 2025, 4:00 PM EST
150.80
+1.58 (1.06%)
After-hours: Dec 5, 2025, 6:19 PM EST
Axsome Therapeutics Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for Axsome Therapeutics stock have an average target of 176, with a low estimate of 143 and a high estimate of 205. The average target predicts an increase of 17.95% from the current stock price of 149.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 6, 2025.
Analyst Ratings
The average analyst rating for Axsome Therapeutics stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 9 |
| Buy | 9 | 10 | 10 | 11 | 11 | 11 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 18 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $200 → $202 | Buy | Maintains | $200 → $202 | +35.37% | Nov 6, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $194 → $196 | Buy | Maintains | $194 → $196 | +31.35% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $180 → $185 | Strong Buy | Maintains | $180 → $185 | +23.98% | Nov 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $189 → $198 | Buy | Maintains | $189 → $198 | +32.69% | Nov 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $163 → $157 | Buy | Maintains | $163 → $157 | +5.21% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
641.02M
from 385.69M
Increased by 66.20%
Revenue Next Year
1.01B
from 641.02M
Increased by 57.56%
EPS This Year
-3.74
from -5.99
EPS Next Year
0.93
from -3.74
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 669.6M | 1.2B | ||||
| Avg | 641.0M | 1.0B | ||||
| Low | 600.7M | 880.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 73.6% | 80.3% | ||||
| Avg | 66.2% | 57.6% | ||||
| Low | 55.8% | 37.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.18 | 3.18 | ||||
| Avg | -3.74 | 0.93 | ||||
| Low | -4.02 | -1.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.